Personalised postprandial-targeting
Personalised postprandial-targeting is a way to modulate water-heme interactions with activity against low-spin P450 complexes. Personalised postprandial-targeting is able to maintain the axial water ligands of CYP2C9 even in the presence of inhibitors. Personalised postprandial-targeting also allows the hydrogen atoms of the axial water ligands to be observed by EPR spectroscopy, providing insights into the enzyme active site[1].
Product Specifications
CAS Number
[1529779-90-5]
UNSPSC
12352005
Target
HBV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/personalised-postprandial-targeting.html
Smiles
C1(CCCC2=CC=CC=C2)=CNN=N1
Molecular Formula
C11H13N3
Molecular Weight
187.24
References & Citations
[1]Drug modulation of water-heme interactions in low-spin P450 complexes of CYP2C9d and CYP125A1
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
HMGN1, NT (HMGN1, HMG14, Non-histone chromosomal protein HMG-14, High mobility group nucleosome-binding domain-containing protein 1) (MaxLight 490) discontinued
NUPL2, NT (NUPL2, CG1, Nucleoporin-like protein 2, NLP-1, NUP42 homolog, Nucleoporin hCG1) (MaxLight 490)
NUPL2, NT (NUPL2, CG1, Nucleoporin-like protein 2, NLP-1, NUP42 homolog, Nucleoporin hCG1) (MaxLight 490)
Lentiviral human IMPA1 shRNA (UAS) - Lentiviral human IMPA1 shRNA (UAS, GFP) (100)